News

August 28, 2019

EMulate Therapeutics® Submits Application for CE Mark

Read More

July 31, 2019

EMulate Therapeutics® Reaches Patent Milestone

Read More

June 18, 2019

FDA Accepts for Filing the Humanitarian Device Exemption Application For EMulate Therapeutics™ Hælo™ Pediatric System

Read More

March 19, 2019

Nativis Announces Name Change To EMulate Therapeutics, Inc.

Read More

February 26, 2019

How far will the Voyager® take us?

Read More

February 19, 2019

Nativis Announces Additional Publication of Further Study in Patients with Recurrent Glioblastoma (rGBM)

Read More

December 18, 2018

Nativis Announces Publication of Study in Patients with Recurrent Glioblastoma (rGBM)

Read More

November 14, 2018

Nativis Announces Early Data from Study in Treatment of Patients with Newly Diagnosed Glioblastoma

Read More

August 8, 2018

Nativis Appoints Andrew Daniels to Board of Directors

Read More

July 5, 2018

Nativis Research Partner Presents at the International Symposium on Pediatric Neuro-Oncology Annual Meeting in Denver

Read More

Older » « Newer